Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine versus sufentanil for cough-related pain after thoracoscopic lung surgery
ChiCTR2600131888Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Oct 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Sufentanil group with Tegileridine group (2 arms). Primary endpoint: Maximum NRS score for cough-related pain. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
tegileridinesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600131888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600131888.